Breast Cancer Prevention in Low and Middle Income Countries

Video

Graham Colditz, MD, DrPH, associate director, Prevention and Control, Alvin J. Siteman Cancer Center, discusses the need to focus on breast cancer prevention in low and middle income countries.

Clinical Pearls

Graham Colditz, MD, DrPH, associate director, Prevention and Control, Alvin J. Siteman Cancer Center, discusses the need to focus on breast cancer prevention in low and middle income countries.

  • Efforts need to be focused on breast cancer prevention in low and middle income countries.
  • About 25% of all cancer diagnosed in women is breast cancer. That proportion will increase as countries go through economic transitions and women have fewer children, learn about better nutrition, and experience earlier onset of menstrual periods.
  • It will be difficult to afford to diagnose and treat breast cancer in low and middle income countries. There is currently no robust prevention focus in these countries.
Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
Related Content